Standout Papers
Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Natural immunity to pluripotency antigen OCT4 in humans
2010
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4
2006
Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe
2002
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
2001 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
2002
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Stat3 as an Oncogene
1999 Standout
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
2001 StandoutNature
Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection
2009
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
2002
Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis
2007
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis
2007
Renal-Cell Carcinoma
2005
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Molecules and mechanisms of the graft-versus-leukaemia effect
2004
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
1998 StandoutNature
Hematopoietic Stem-Cell Transplantation
2006 Standout
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
A completely biological tissue-engineered human blood vessel
1998
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
TAP off - tumors on
1997
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Recent advances in the discovery and delivery of vaccine adjuvants
2003
CONTROL OF LMP7 EXPRESSION IN HUMAN ENDOTHELIAL CELLS BY CYTOKINES REGULATING CELLULAR AND HUMORAL IMMUNITY
2000
Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells
2002
Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines
2001
Chronic Myeloid Leukemia
1999
Autophagy in immunity and inflammation
2011 StandoutNature
MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma
2003
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.
2001
Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection
2002
Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity
2007
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
B7x: A widely expressed B7 family member that inhibits T cell activation
2003 StandoutNobel
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.
2002
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma
2004
Functional Arteries Grown in Vitro
1999 StandoutScience
Expression and Regulation of the PD-L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells
2002
Cancer Immunotherapy: A Treatment for the Masses
2004 Science
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
2003
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
Interferon Induction of TAP1
1998
Synergistic Induction of the Tap-1 Gene by IFN-γ and Lipopolysaccharide in Macrophages Is Regulated by STAT1
2000
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
CELLULAR RESPONSES TO INTERFERON-γ
1997 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
1997 StandoutNobel
Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.
2001
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma
2004
RNA Scanning of a Molecular Machine with a Built-in Ruler
2016 StandoutNobel
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Endothelial Cells in Allograft Rejection
2008
A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma
2002
Antigen Recognition Is Facilitated by Invadosome-like Protrusions Formed by Memory/Effector T Cells
2012
Inactivation of von Hippel-Lindau Gene Induces Constitutive Phosphorylation of MET Protein in Clear Cell Renal Carcinoma
2006
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
2000
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation
1999 StandoutScience
Works of Diane E. Epperson being referenced
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Molecular remission of chronic myeloid leukaemia following a non‐myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft‐versus‐leukaemia effect
1999
Dermal Microvascular Injury in the Human Peripheral Blood Lymphocyte Reconstituted-Severe Combined Immunodeficient (HuPBL-SCID) Mouse/Skin Allograft Model Is T Cell Mediated and Inhibited by a Combination of Cyclosporine and Rapamycin
1998
Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells.
1992
Immunostimulant Patch Containing Heat-Labile Enterotoxin fromEscherichia coliEnhances Immune Responses to Injected Influenza Virus Vaccine through Activation of Skin Dendritic Cells
2003
Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer
2009
Antigen-presenting function of human endothelial cells. Direct activation of resting CD8 T cells.
1994